Basic and escalation therapy of multiple sclerosis

ISSN： 2195-2175

Source： PHARMAKON, Vol.2, Iss.6, 2014-11, pp. : 414-421

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Induction and Escalation Therapies in Multiple Sclerosis

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 14, Iss. 1, 2015-03 ,pp. : 26-34

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in Antioxidative Therapy of Multiple Sclerosis

Current Medicinal Chemistry, Vol. 20, Iss. 37, 2013-11 ,pp. : 4720-4730

Bentham Science Publishers

Access to resources Recommend Favorite

Teriflunomide for oral therapy in multiple sclerosis

By Papadopoulou Athina Kappos Ludwig Sprenger Till

Expert Review of Clinical Pharmacology, Vol. 5, Iss. 6, 2012-11 ,pp. : 617-628

Informa Healthcare

Access to resources Recommend Favorite

Managing the Adverse Effects of Interferon- Therapy in Multiple Sclerosis

By Bayas A. Rieckmann P.

Drug Safety, Vol. 22, Iss. 2, 2000-02 ,pp. : 149-159

Adis International

Access to resources Recommend Favorite

Choosing Drug Therapy for Multiple Sclerosis: An Update

By van Oosten B.W.

Drugs, Vol. 56, Iss. 4, 1998-10 ,pp. : 555-569

Adis International

Access to resources Recommend Favorite